Holen Sie sich die Stockscreener-App
236.43
0.22%
-0.53
Handel nachbörslich:
236.43
Schlusskurs vom Vortag:
$236.96
Offen:
$235.52
24-Stunden-Volumen:
822.38K
Relative Volume:
0.72
Marktkapitalisierung:
$38.38B
Einnahmen:
$2.75B
Nettoeinkommen (Verlust:
$714.14M
KGV:
54.60
EPS:
4.33
Netto-Cashflow:
$1.09B
1W Leistung:
+2.05%
1M Leistung:
+1.55%
6M Leistung:
+9.72%
1J Leistung:
+3.50%
1-Tages-Spanne:
$233.83
$237.09
1-Wochen-Bereich:
$226.55
$238.13
52-Wochen-Spanne:
$170.25
$258.93
Veeva Systems Inc Stock (VEEV) Company Profile
Firmenname
Veeva Systems Inc
Sektor
Branche
Telefon
925-452-6500
Adresse
4280 HACIENDA DRIVE, PLEASANTON, CA
Vergleichen Sie VEEV mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
VEEV
Veeva Systems Inc
|
236.43 | 38.38B | 2.75B | 714.14M | 1.09B | 4.33 |
|
SOLV
Solventum Corp
|
75.30 | 13.03B | 8.26B | 66.00M | 1.17B | 0.3682 |
|
DOCS
Doximity Inc
|
61.31 | 11.50B | 516.85M | 174.11M | 217.38M | 0.87 |
|
HQY
Healthequity Inc
|
101.67 | 8.81B | 1.15B | 96.70M | -161.99M | 1.09 |
|
TEM
Tempus Ai Inc
|
45.74 | 7.88B | 640.44M | -743.28M | -206.93M | -11.29 |
Veeva Systems Inc Stock (VEEV) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-01-23 | Herabstufung | Goldman | Buy → Sell |
| 2024-12-20 | Eingeleitet | Stephens | Overweight |
| 2024-12-04 | Eingeleitet | Mizuho | Outperform |
| 2024-11-19 | Eingeleitet | Scotiabank | Sector Perform |
| 2024-10-08 | Eingeleitet | Exane BNP Paribas | Outperform |
| 2024-08-27 | Bestätigt | Citigroup | Buy |
| 2024-07-09 | Eingeleitet | BTIG Research | Buy |
| 2023-10-25 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2023-10-13 | Eingeleitet | Jefferies | Buy |
| 2023-06-28 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2023-06-01 | Hochstufung | Guggenheim | Neutral → Buy |
| 2023-03-17 | Herabstufung | Truist | Buy → Hold |
| 2023-02-23 | Herabstufung | Guggenheim | Buy → Neutral |
| 2023-01-04 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2022-12-06 | Eingeleitet | Cowen | Market Perform |
| 2022-12-02 | Bestätigt | Needham | Buy |
| 2022-10-31 | Eingeleitet | Wells Fargo | Equal Weight |
| 2022-10-19 | Hochstufung | JP Morgan | Underweight → Neutral |
| 2022-09-16 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2022-07-27 | Eingeleitet | Oppenheimer | Outperform |
| 2022-06-23 | Eingeleitet | Goldman | Buy |
| 2022-06-21 | Fortgesetzt | Guggenheim | Buy |
| 2022-03-03 | Herabstufung | BofA Securities | Buy → Neutral |
| 2022-01-28 | Eingeleitet | Truist | Buy |
| 2022-01-07 | Herabstufung | Stephens | Overweight → Equal-Weight |
| 2022-01-06 | Hochstufung | SVB Leerink | Mkt Perform → Outperform |
| 2021-12-16 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2021-10-01 | Fortgesetzt | Stifel | Buy |
| 2021-09-02 | Bestätigt | BofA Securities | Buy |
| 2021-09-02 | Bestätigt | JMP Securities | Mkt Outperform |
| 2021-09-02 | Bestätigt | Needham | Buy |
| 2021-09-02 | Bestätigt | UBS | Neutral |
| 2021-07-21 | Eingeleitet | Cowen | Outperform |
| 2021-03-31 | Hochstufung | UBS | Sell → Neutral |
| 2021-01-07 | Fortgesetzt | KeyBanc Capital Markets | Overweight |
| 2020-12-09 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2020-10-14 | Fortgesetzt | UBS | Sell |
| 2020-08-28 | Bestätigt | Needham | Buy |
| 2020-07-23 | Eingeleitet | FBN Securities | Outperform |
| 2020-07-07 | Eingeleitet | Stephens | Overweight |
| 2020-06-08 | Eingeleitet | Citigroup | Buy |
| 2020-05-29 | Bestätigt | Needham | Buy |
| 2020-04-13 | Eingeleitet | SVB Leerink | Mkt Perform |
| 2020-02-19 | Eingeleitet | Robert W. Baird | Outperform |
| 2020-02-14 | Eingeleitet | Piper Sandler | Overweight |
| 2020-01-13 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2019-11-27 | Bestätigt | Canaccord Genuity | Hold |
| 2019-09-26 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2019-08-28 | Bestätigt | Needham | Buy |
| 2019-06-07 | Eingeleitet | Goldman | Neutral |
| 2019-05-30 | Bestätigt | BofA/Merrill | Buy |
| 2019-05-30 | Hochstufung | Stephens | Equal-Weight → Overweight |
| 2019-05-24 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2019-04-17 | Bestätigt | Needham | Buy |
| 2019-02-27 | Bestätigt | Needham | Buy |
Alle ansehen
Veeva Systems Inc Aktie (VEEV) Neueste Nachrichten
Clinical Data Management Systems (CDMS) Market Next Big Thing: Major Giants- Oracle, Veeva Systems, Parexel - openPR
Best Momentum Stock to Buy for March 17th - TradingView
Electronic Clinical Outcome Assessment (eCOA) Solution Market - openPR
Here's Why You Should Add Veeva Systems Stock to Your Portfolio Now - MSN
Veeva Shares Advance on Revenue, AI Growth - FX Empire
Veeva Systems (NYSE:VEEV) Announces Tina Hunt's Retirement From Board Before 2025 Shareholders Meeting - Yahoo Finance
Veeva Systems' (NYSE:VEEV) Earnings May Just Be The Starting Point - Simply Wall St
Solid Earnings Reflect Veeva Systems' (NYSE:VEEV) Strength As A Business - Yahoo Finance
Veeva Systems Inc.’s SWOT analysis: cloud software stock faces growth challenges - Investing.com
Veeva Systems Inc. (VEEV): A Bull Case Theory - MSN
Veeva Systems announces board member retirement - Investing.com
Veeva Systems announces board member retirement By Investing.com - Investing.com Australia
Veeva Systems Announces Board Member Retirement - TipRanks
Boehringer launches unified platform with Veeva - The Pharma Letter
Top Global Biopharmas Standardize on Veeva China CRM Suite - GuruFocus.com
Veeva Systems Inc (VEEV) Stock Price, Trades & News - GuruFocus.com
Veeva (VEEV) Upgraded to Strong Buy: Here's Why - Yahoo Finance
Boehringer Ingelheim Partners with Veeva to Launch ‘One Medicine Platform’ - Veeva
Boehringer Ingelheim Partners With Veeva To Launch 'One Medicine Platform' -March 11, 2025 at 07:03 am EDT - Marketscreener.com
Veeva Powers Boehringer's Game-Changing One Medicine Platform for Drug Development - StockTitan
Veeva Systems Inc. (NYSE:VEEV) Stock Position Decreased by Mutual of America Capital Management LLC - Defense World
Veeva Systems (NYSE:VEEV) Surges 10% After Strong Earnings Report - Yahoo Finance
Scotiabank Forecasts Strong Price Appreciation for Veeva Systems (NYSE:VEEV) Stock - Defense World
Regulatory Information Management Software Market to See Revolutionary Growth: Sparta Systems, Veeva Systems - openPR
Veeva Systems Inc. (NYSE:VEEV) Just Released Its Yearly Earnings: Here's What Analysts Think - Simply Wall St
Robert W. Baird Forecasts Strong Price Appreciation for Veeva Systems (NYSE:VEEV) Stock - Defense World
Needham & Company LLC Reaffirms “Buy” Rating for Veeva Systems (NYSE:VEEV) - Defense World
Veeva Systems (NYSE:VEEV) Earns “Overweight” Rating from Stephens - Defense World
Veeva Systems (NYSE:VEEV) Stock Price Expected to Rise, Morgan Stanley Analyst Says - Defense World
Biotech Stocks To Follow Now – March 6th - Defense World
Veeva Systems Inc. (NYSE:VEEV) Q4 2025 Earnings Call Transcript - MSN
VEEV Stock Gains Following Latest Availability of HCP Access Data - Nasdaq
Veeva price target raised to $245 from $240 at Scotiabank - Yahoo Finance
Veeva Systems: Solid Q4 With Margin Expansion (NYSE:VEEV) - Seeking Alpha
Veeva Systems: Strong Financial Performance and Strategic Positioning Drive Buy Rating - TipRanks
Veeva Systems (NYSE:VEEV) Shares Gap Up on Analyst Upgrade - Defense World
Veeva Systems Inc Class A to Host Earnings Call - ACCESS Newswire
Veeva Systems’ Earnings Call Highlights Strong Growth and Strategic Wins - TipRanks
Veeva Systems, Eli Lilly, Zscaler Among 16 New Names On IBD 50 Hot List - Investor's Business Daily
Why Veeva Systems (VEEV) Is Rallying Today - MSN
Veeva Systems (VEEV) Stock Trades Up, Here Is Why - Barchart
Why Veeva Systems Stock Is Surging Today - Mitrade
BJ's Wholesale Club Posts Better-Than-Expected Earnings, Joins Burlington Stores, Veeva Systems And Other Big Stocks Moving Higher On Thursday - Benzinga
Citi maintains Veeva stock Buy rating, $307 target post Q4 beat - Investing.com India
Stifel maintains Veeva stock Buy rating, $272 target post-earnings - Investing.com India
Market Whales and Their Recent Bets on VEEV Options - Benzinga
Citi Reiterates Buy Rating on Veeva Systems (VEEV) - StreetInsider.com
Veeva Systems Inc. (VEEV) Stock Forecasts - Yahoo Finance
Stifel maintains Veeva stock Buy rating, $272 target post-earnings By Investing.com - Investing.com UK
Veeva Earnings: Finishes the Year on a Strong Note With a Robust Growth Outlook - Morningstar
Veeva stock price target raised to $261 at TD Cowen - Investing.com India
Finanzdaten der Veeva Systems Inc-Aktie (VEEV)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.20%
1.79%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):